Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Clinical Trial Agent (TBN) in Breast Dysplasia
Fabian, Carol J.
University of Kansas, Kansas City, KS, United States
Search 29 grants from Carol Fabian
Search grants from University of Kansas
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Early Detection of Osteoarthritis
Ion Channels and Calcium Release in Muscle
Job Exit Behavior of Older Workers
Behavior
Mathematical Sciences: Research in Geometrical Analysis
Recently added grants:
Developmental Pesticide Exposure and Epigenetic Aging in the Brain
IL-21 as a Therapeutic to Reduce Immune Activation and Normalize Microbial Dysbiosis in SIV-Infected ART-Suppressed Infant Macaques
Talin1 Function in Cardiac Myofibroblasts
Patterning the Vertebrate Dentition Through Replacement and Repair
Evaluating State-Based Network Dynamics in Anhedonia
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN065124-000
Application #
2357688
Study Section
Project Start
1996-09-26
Project End
Budget Start
1996-09-26
Budget End
1998-09-29
Support Year
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
University of Kansas
Department
Pharmacology
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Related projects
NIH 1999
N01 CN
Phase 2 Clinical Trial Agent (TBN) in Breast Dysplasia
Fabian, Carol J. / University of Kansas
NIH 1998
N01 CN
Phase 2 Clinical Trial Agent (TBN) in Breast Dysplasia
Fabian, Carol J. / University of Kansas
NIH 1996
N01 CN
Phase 2 Clinical Trial Agent (TBN) in Breast Dysplasia
Fabian, Carol J. / University of Kansas
Publications
Fabian, Carol J; Kimler, Bruce F; Brady, Deborah A et al.
(2002)
A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers.
Clin Cancer Res 8:3105-17
Comments
Be the first to comment on Carol Fabian's grant